Makes the mu-opioid receptor (target of endorphins and opioid painkillers). The G variant (A118G, common in some populations) reduces receptor availability/efficiency, meaning those people may feel more pain and get less relief from opioids, and may have higher risk of opioid addiction or need higher doses for pain.